Johns Hopkins researchers have discovered that a single protein molecule may hold the key to turning cardiac stem cells into blood vessels or muscle tissue, a finding that may lead to better ways to treat heart attack patients.
Jun 20, 2012
0
0
A new research report published in the Journal of Leukocyte Biology shows how the bacteria known for causing gum disease—Porphyromonas gingivalis—manipulates the body's immune system to disable normal processes that would ...
Jan 3, 2013
0
0
Yale researchers have developed a set of synthetic molecules that may help boost the strength of a key, virus-fighting protein.
Feb 22, 2018
1
60
RUDN chemists synthesized a range of biologically active molecules called chromones and demonstrated their use in the treatment of Alzheimer's disease. The results of the work were published in the Bioorganic & Medicinal ...
Nov 14, 2018
0
16
Early laboratory tests are the first to successfully use an experimental molecular therapy to block a hard-to-target part of a protein complex linked to several types of invasive cancer.
Feb 5, 2013
0
0
Research from Johns Hopkins Kimmel Cancer Center experts revealed a type of RNA, previously considered to be "junk," that may help doctors distinguish and treat a subgroup of patients with medulloblastoma.
Mar 23, 2023
0
27
A small group of immune-regulating molecules, when overproduced even moderately, can trigger the blood cancers known as lymphomas, according to a new study led by scientists from The Scripps Research Institute (TSRI).
Aug 8, 2013
0
0
Researchers at the University of Gothenburg have discovered that a chemical can trigger the maturation of small eggs to healthy, mature eggs, a process that could give more women the chance of successful IVF treatment in ...
Sep 24, 2012
0
0
Nature gave ticks, mosquitoes and leeches a quick-acting way to keep blood from clotting while they extract their meal from a host. Now the key to that method has been harnessed by a team of Duke researchers as a potential ...
May 13, 2024
0
56
Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
May 21, 2013
0
0
